Designates November of each year as "Diabetes and Cardiovascular Disease Awareness Month."
The resolution acknowledges that diabetes is a pervasive chronic condition affecting more than 29 million Americans, with type 2 diabetes being the most common form. Importantly, cardiovascular disease remains the leading cause of death for individuals with diabetes, accounting for a substantial number of fatalities. By designating a specific month for awareness, the state aims to foster greater understanding and encourage preventive measures among its residents, thereby potentially mitigating this public health crisis.
AJR59 is a Joint Resolution introduced in the New Jersey legislature, designating November of each year as 'Diabetes and Cardiovascular Disease Awareness Month.' This initiative aims to raise public awareness about the critical link between diabetes and cardiovascular disease, emphasizing the importance of education in recognizing and addressing these health issues. Given the significant health implications and economic burdens associated with these conditions, the resolution seeks to enlighten the public and encourage proactive health measures.
The legislators supporting AJR59 highlight the staggering statistics that illustrate the severity of diabetes and its complications, with millions of Americans undiagnosed and a significant percentage unaware of their risks. This initiative not only addresses individual health outcomes but also seeks to reduce the financial impact of diabetes and cardiovascular diseases on the state's healthcare system, which has considerable Medicare expenditures for affected populations. The resolution serves as a call to action for community education, particularly within high-risk demographics, including African American and Hispanic populations who face elevated risks of these diseases.